348 related articles for article (PubMed ID: 11776840)
21. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
[TBL] [Abstract][Full Text] [Related]
22. [Exploration of indication of prophylactic transcatheter arterial chemoembolization on postoperative recurrence of hepatocellular carcinoma].
Wang QX; Yan JJ; Zhou FG; Shen J; Yan YQ
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):748-51. PubMed ID: 19615209
[TBL] [Abstract][Full Text] [Related]
23. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
[TBL] [Abstract][Full Text] [Related]
24. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Wu DH; Chen LH
Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
[TBL] [Abstract][Full Text] [Related]
26. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
[TBL] [Abstract][Full Text] [Related]
27. Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients.
Di Carlo V; Ferrari G; Castoldi R; De Nardi P; Bergamo C; Taccagni G; Salvioni M; Angeli E; Venturini M; Del Maschio A
Hepatogastroenterology; 1998; 45(24):1950-4. PubMed ID: 9951846
[TBL] [Abstract][Full Text] [Related]
28. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T;
Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097
[TBL] [Abstract][Full Text] [Related]
29. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
Chen XP; Hu DY; Zhang ZW; Zhang BX; Chen YF; Zhang WG; Qiu FZ
Dig Surg; 2007; 24(3):208-13. PubMed ID: 17522469
[TBL] [Abstract][Full Text] [Related]
30. [Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor].
Ren ZG; Lin ZY; Xia JL; Zhang BH; Ye SL; Chen SY; Gan YH; Wu XF; Chen Y; Ge NL; Wu ZQ; Ma ZC; Zhou XD; Fan J; Qin LX; Ye QH; Sun HC; Zhou J; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):116-8. PubMed ID: 15059334
[TBL] [Abstract][Full Text] [Related]
31. The effect of postoperative TACE on prognosis of HCC with microscopic venous invasion.
Ke-Wei L; Tian-Fu W; Xi L; Lü-Nan Y; Bo L; Yong Z; Wu-Sheng L; Wen-Tao W; Ming-Qing X; Jia-Yin Y; Yu-Kui M; Zhe-Yu C
Hepatogastroenterology; 2012 Sep; 59(118):1944-6. PubMed ID: 22246191
[TBL] [Abstract][Full Text] [Related]
32. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
[TBL] [Abstract][Full Text] [Related]
33. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Zhang Z; Wu M; Chen H; Chen D; He J
Zhonghua Wai Ke Za Zhi; 2002 Nov; 40(11):826-9. PubMed ID: 12487855
[TBL] [Abstract][Full Text] [Related]
34. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
35. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
[TBL] [Abstract][Full Text] [Related]
36. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
[TBL] [Abstract][Full Text] [Related]
37. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
Lu W; Li Y; He X; Chen Y
Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
[TBL] [Abstract][Full Text] [Related]
38. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
Zhou WP; Lai EC; Li AJ; Fu SY; Zhou JP; Pan ZY; Lau WY; Wu MC
Ann Surg; 2009 Feb; 249(2):195-202. PubMed ID: 19212170
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
Xi T; Lai EC; Min AR; Shi LH; Wu D; Xue F; Wang K; Yan Z; Xia Y; Shen F; Lau WY; Wu MC
Hepatogastroenterology; 2012 Jun; 59(116):1198-203. PubMed ID: 22580673
[TBL] [Abstract][Full Text] [Related]
40. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
